Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Vinik

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Journal of Diabetes Research|June 11, 2015
Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes MellitusBindu Chamarthi, J Michael Gaziano, Lawrence Blonde, et al.
The Oncologist|October 18, 2017
Patient-Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo-Controlled, Double-Blind and 32-Week Open-Label StudyGeorge A Fisher, Edward M Wolin, Nilani Liyanage, et al.
Annals of Clinical and Translational Neurology|May 23, 2015
Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathyJohn A Kessler, A Gordon Smith, Bong-Soo Cha, et al.
International Journal of Clinical Practice|February 7, 2021
Factors influencing the quality of life over a 4-year period of time in Romanian patients with diabetes mellitusCamelia Larisa Vonica, Norina Alinta Gâvan, Daniel-Tudor Cosma, et al.
Primary Care Diabetes|August 1, 2022
Predictive value of a novel sub-item mortality risk score derived from the Norfolk Quality of Life in Diabetic Neuropathy questionnaire in Romanian participants with diabetes mellitusCosmina Ioana Bondor, Daniel-Tudor Cosma, Bogdan Florea, et al.
Clinical Endocrinology|October 24, 2006
Clinical features and morphological characterization of 10 patients with noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS)Justin G S Won, Hsiao-Shan Tseng, An-Hang Yang, et al.
Diabetes Care|September 30, 2010
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatmentsSolomon Tesfaye, Andrew J M Boulton, Peter J Dyck, et al.
Targeted Oncology|December 8, 2016
Patient-Reported Outcomes and Quality of Life with Sunitinib Versus Placebo for Pancreatic Neuroendocrine Tumors: Results From an International Phase III TrialAaron Vinik, Andrew Bottomley, Beata Korytowsky, et al.
The New England Journal of Medicine|February 11, 2011
Sunitinib malate for the treatment of pancreatic neuroendocrine tumorsEric Raymond, Laetitia Dahan, Jean-Luc Raoul, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Journal of Diabetes Research|June 11, 2015
Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes MellitusBindu Chamarthi, J Michael Gaziano, Lawrence Blonde, et al.
The Oncologist|October 18, 2017
Patient-Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo-Controlled, Double-Blind and 32-Week Open-Label StudyGeorge A Fisher, Edward M Wolin, Nilani Liyanage, et al.
Annals of Clinical and Translational Neurology|May 23, 2015
Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathyJohn A Kessler, A Gordon Smith, Bong-Soo Cha, et al.
International Journal of Clinical Practice|February 7, 2021
Factors influencing the quality of life over a 4-year period of time in Romanian patients with diabetes mellitusCamelia Larisa Vonica, Norina Alinta Gâvan, Daniel-Tudor Cosma, et al.
Primary Care Diabetes|August 1, 2022
Predictive value of a novel sub-item mortality risk score derived from the Norfolk Quality of Life in Diabetic Neuropathy questionnaire in Romanian participants with diabetes mellitusCosmina Ioana Bondor, Daniel-Tudor Cosma, Bogdan Florea, et al.
Clinical Endocrinology|October 24, 2006
Clinical features and morphological characterization of 10 patients with noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS)Justin G S Won, Hsiao-Shan Tseng, An-Hang Yang, et al.
Diabetes Care|September 30, 2010
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatmentsSolomon Tesfaye, Andrew J M Boulton, Peter J Dyck, et al.
Targeted Oncology|December 8, 2016
Patient-Reported Outcomes and Quality of Life with Sunitinib Versus Placebo for Pancreatic Neuroendocrine Tumors: Results From an International Phase III TrialAaron Vinik, Andrew Bottomley, Beata Korytowsky, et al.
The New England Journal of Medicine|February 11, 2011
Sunitinib malate for the treatment of pancreatic neuroendocrine tumorsEric Raymond, Laetitia Dahan, Jean-Luc Raoul, et al.
Pageof 5